Filing Details
- Accession Number:
- 0001223203-10-000308
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-24 14:20:57
- Reporting Period:
- 2010-11-23
- Filing Date:
- 2010-11-24
- Accepted Time:
- 2010-11-24 14:20:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1385187 | Covidien Plc | COV | Surgical & Medical Instruments & Apparatus (3841) | 980624794 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1400564 | Iii N Coleman Lannum | Covidien Ltd. 15 Hampshire Street Mansfield MA 02048 | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2010-11-23 | 8,700 | $42.33 | 15,849 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2010-11-24 | 5,855 | $42.38 | 9,994 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2010-11-24 | 485 | $0.00 | 9,509 | No | 5 | G | Direct | |
Ordinary Shares | Acquisiton | 2010-11-24 | 33 | $0.00 | 233 | No | 5 | G | Indirect | By son (M) |
Ordinary Shares | Acquisiton | 2010-11-24 | 33 | $0.00 | 233 | No | 5 | G | Indirect | By son (R) |
Ordinary Shares | Acquisiton | 2010-11-24 | 33 | $0.00 | 233 | No | 5 | G | Indirect | By son (S) |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 5 | G | Direct | |
No | 5 | G | Indirect | By son (M) |
No | 5 | G | Indirect | By son (R) |
No | 5 | G | Indirect | By son (S) |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Ordinary Shares | 350 | Indirect | By mother |
Ordinary Shares | 1,441 | Indirect | By Wife |
Footnotes
- The price reported is a weighted average price. Shares were sold in multiple transactions at prices ranging from $42.33 to $42.34. The Reporting Person will provide, upon request by the Commission staff, the Issuer,or a securityholder of the Issuer, full information regarding the number of shares sold at each separate price.
- Includes 12 shares acquired in connection with the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4.
- The price reported is a weighted average price. Shares were sold in multiple transactions at prices ranging from $42.32 to $42.56. The Reporting Person will provide, upon request by the Commission staff, the Issuer,or a securityholder of the Issuer, full information regarding the number of shares sold at each separate price.